KCNN1 (Potassium Calcium-Activated Channel Subfamily N Member 1), also known as SK1 (Small-Conductance Calcium-Activated Potassium Channel 1), encodes a neuronal small-conductance calcium-activated potassium channel. These channels play critical roles in regulating neuronal excitability, synaptic integration, and afterhyperpolarization. SK channels are increasingly recognized as important therapeutic targets in neurodegenerative diseases, epilepsy, and psychiatric disorders.
KCNN1 is located on chromosome 1p22 and encodes the SK1 channel protein. The gene is catalogued as NCBI Gene ID 3776 and OMIM 609921. SK channels belong to the family of small-conductance calcium-activated potassium channels that regulate neuronal firing patterns and synaptic plasticity.
| Property |
Value |
| Gene Symbol |
KCNN1 |
| Full Name |
Potassium Calcium-Activated Channel Subfamily N Member 1 |
| Aliases |
SK1, KCa2.1, hSK1 |
| Chromosomal Location |
1p22 |
| NCBI Gene ID |
3776 |
| OMIM |
609921 |
| Ensembl ID |
ENSG00000105695 |
| UniProt ID |
Q9H5Y3 |
¶ Protein Structure and Function
KCNN1 encodes a subunit of the small-conductance calcium-activated potassium (SK) channel. Key structural features include:
- Six transmembrane domains (S1-S6)
- Pore loop between S5 and S6
- Calmodulin-binding domain in the C-terminus for calcium sensing
- Homotetrameric assembly to form functional channels
SK channels are uniquely gated by intracellular calcium through calmodulin binding, making them ideal sensors of neuronal calcium dynamics.
- Afterhyperpolarization: SK channels contribute to the medium afterhyperpolarization (mAHP) following action potentials, limiting neuronal firing rates
- Synaptic integration: Regulate dendritic integration of synaptic inputs
- Pacemaker activity: Control rhythmic firing in specialized neurons
- Learning and memory: SK channel plasticity in hippocampal neurons is essential for hippocampal-dependent learning
- Motor coordination: Cerebellar SK channels regulate Purkinje cell firing and motor learning
KCNN1 is widely expressed in the central nervous system:
- Hippocampus: CA1 pyramidal neurons, interneurons
- Cortex: Layer 2/3 pyramidal neurons, cortical interneurons
- Cerebellum: Purkinje cells, granule cells
- Thalamus: Relay neurons
- Brainstem: Auditory brainstem neurons
- Spinal cord: Motor neurons, interneurons
Expression data is available from the Allen Human Brain Atlas.
SK channels are critically involved in Alzheimer's disease pathophysiology:
- Amyloid-beta effects: Aβ oligomers dysregulate SK channel function in hippocampal neurons, contributing to hippocampal hyperexcitability
- Tau pathology: Hyperphosphorylated tau alters SK channel expression and function
- Synaptic dysfunction: SK channel downregulation contributes to synaptic plasticity deficits
- Therapeutic potential: SK channel activators (e.g., chlorzoxazone) improve cognitive function in AD models
- Dopaminergic neuron survival: SK channels protect substantia nigra pars compacta neurons from oxidative stress
- Motor complications: SK channel dysfunction may contribute to levodopa-induced dyskinesias
- Basal ganglia circuitry: SK channels regulate firing patterns in striatal medium spiny neurons
- Motor neuron excitability: SK channel alterations contribute to hyperexcitability in ALS motor neurons
- Glial involvement: Astrocytic SK channel dysfunction affects motor neuron survival
- Therapeutic targeting: SK channel modulators show promise in preclinical ALS models
- Seizure suppression: SK channel activators reduce seizure frequency and severity
- Hippocampal hyperexcitability: SK channel downregulation contributes to epileptogenesis
- Status epilepticus: SK channels are dysregulated during prolonged seizures
- Stroke: SK channel activation reduces ischemic neuronal damage
- Depression: SK channel dysfunction in prefrontal cortex may contribute to mood disorders
- Schizophrenia: Altered SK channel expression in relevant brain regions
- Migraine: SK channels in trigeminal neurons involved in migraine pathophysiology
SK channels represent promising drug targets:
- Chlorzoxazone: FDA-approved muscle relaxant that activates SK channels; being repurposed for AD
- NS309: Potent SK channel activator with neuroprotective properties
- Apo-E4 effects: SK channel modulators may counteract Apo-E4-induced synaptic deficits
- Gene therapy: Viral vector delivery of KCNN1 for sustained SK channel upregulation
KCNN1 interacts with several important proteins:
- Calmodulin: Calcium sensor required for channel gating
- Cav2.1 (P/Q-type calcium channels): Source of calcium for SK activation
- NMDA receptors: Provide calcium for SK channel activation
- FKBP12: Immunophilin that modulates channel trafficking
- CASK: Scaffold protein involved in synaptic localization
- Knockout mice: KCNN1-/- mice show increased neuronal excitability and memory deficits
- Pharmacological tools: Specific activators (NS309, chlorzoxazone) and blockers (apamin, UCLX1848)
- Animal models: Transgenic AD/PD models used to study SK channel dysfunction
KCNN1 encodes the SK1 small-conductance calcium-activated potassium channel, which plays essential roles in neuronal excitability regulation, synaptic plasticity, and afterhyperpolarization. Dysregulation of KCNN1 contributes to the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, epilepsy, and other neurological disorders. SK channel activators represent promising therapeutic strategies for neurodegenerative diseases.